Medical Health & Life Science Research News

Patients & doctors alike find new hope in North America injectable drug delivery market of healthcare examined in new market research report

Patients & doctors alike find new hope in North America injectable drug delivery market of healthcare examined in new market research report

North America Injectable Drug Delivery Market is expected to reach USD 354.53 billion by 2024 from USD 154.05 billion in 2016, at a CAGR of 5.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

- Advertising -

North America Injectable Drug Delivery Market – By Type {Devices (Conventional, Self), Formulations (Conventional, Noble, Long Acting)} Applications (Autoimmune Diseases, Hormonal Disorders, Others) Usage Pattern (Curative Care, Immunizations, Other Usage Patterns) Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies) Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

Request for [email protected] databridgemarketresearch.com/toc/?…g-delivery-market

The major factors driving the growth of this market are the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others), rapidly increasing aging population and the subsequent rise in chronic conditions, rising demand of self injection devices, technological advancement and innovations in drug delivery market. On the other hand, risk of needle-stick injuries and side effect such as such as feeling sick, abdominal pain, upset stomach, headache, rash, and indigestion may hinder the growth of the market.

Market Segmentation: North America Injectable Drug Delivery Market

The North America injectable drug delivery market Analysis is segmented on the basis of type, application, usage pattern, mode administration, end user, and distribution channel. The North America injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation.

- Advertising -

In 2017, the North America injectable drug delivery formulation market segment is expected to account for the largest share of 67.2% of the North America injectable drug delivery market, by type.

Injectable drug delivery device market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases and other diseases on the basis of application. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others.

Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The hormonal disorders is one of the dominating sectors of North America injectable drug delivery market.

Browse Full Report @ databridgemarketresearch.com/repor…-delivery-market/

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024.

Key Drivers: North America Injectable Drug Delivery Market

Some of the major factors driving the market forinjectable drug delivery market Report are increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes.

Increasing prevalence of chronic diseases, rising demand for self-injection devices, growth of the biologics, and technological advancements are the major factors driving the growth of the injectable drug delivery market.

Request For Sample: databridgemarketresearch.com/reque…g-delivery-market

  • Needlestick injuries and infections, regulatory hurdles, and preference for alternate modes of drug delivery are the factors which may hinder the growth of this market.
  • Many companies are increasingly focusing on biologics and self-injection devices in order to strengthen their product portfolios in the injectable drug delivery market.
  • Development of self-injection devices is changing the trend for the administration of injections in the healthcare sector.
  • Increasing demand for biosimilars and generic injectables will drive the market in future.

Table Of Content

  1. INTRODUCTION

       1.1. OVERVIEW OF THE NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET

       1.2. MARKET SEGMENTATION & COVERAGE

  1. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS

       2.2. ARRIVING AT THE NORTH AMERICA  INJECTABLE DRUG DELIVERY MARKET SIZE

  1. MARKET LANDSCAPE SUMMARY
  2. PREMIUM INSIGHTS

       4.1. OVERVIEW

       4.2.NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS

       4.3. MARKET OVERVIEW

       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5.NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY TYPE

       5.1. OVERVIEW

       5.2. NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES

       5.3.NORTH AMERICA INJECTABLE DRUG DELIVERY FORMULATIONS

6.NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE

       6.1. OVERVIEW

       6.2. CONVENTIONAL INJECTION DEVICES

       6.3. SELF INJECTION DEVICES

                6.3.1. NEEDLE FREE INJECTORS

                6.3.2. AUTOINJECTORS

                6.3.3. PEN INJECTORS

                6.3.4. WEARABLE INJECTORS

                6.3.5. OTHER INJECTABLE DEVICES

  1.  NORTH AMERICA INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE

       7.1. OVERVIEW

       7.2. CONVENTIONAL DRUG DELIVERY FORMULATIONS

       7.3. NOVEL DRUG DELIVERY FORMULATIONS

8.NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATIONS

       8.1. OVERVIEW

       8.2. AUTOIMMUNE DISEASES

       8.3. HORMONAL DISORDERS

       8.4. ORPHAN DISEASES

       8.5. ONCOLOGY

       8.6. OTHERS        

  1. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN

       9.1. OVERVIEW

  1. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION

       10.1. OVERVIEW

  1. INJECTABLE DRUG DELIVERY MARKET, BY END USER

       11.1. OVERVIEW

  1. INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY

       12.1. COUNTRYWISE  INJECTABLE DRUG DELIVERY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS   REPRESENTED IN THIS CHAPTER BY COUNTRY)

                12.1.1. NORTH AMERICA

                                         12.1.1.1. U.S.

                                         12.1.1.2. CANADA

                                          12.1.1.3. MEXICO

       12.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE

       13.1.NORTH AMERICA  INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

       13.2. U.S. INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

       13.3. CANADA INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

       13.4. MAXICO INJECTABLE DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

  1. INJECTABLE DRUG DELIVERY MARKET, COMPANY PROFILES

       14.1. BAXTER INTERNATIONAL, INC.

       14.2. BECTON, DICKINSON AND COMPANY

       14.3. GERRESHEIMER, AG

       14.4. PFIZER, INC.

       14.5. SCHOTT AG

       14.6. ALKERMES PLC

Continoue… Key Points: North America Injectable Drug Delivery Market

Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Bespak, Antares Pharma,Elcam Medical, Haselmeier, Mylan N.V., Novo Nordisk, Owen Mumford Ltd,Sanofi, West Pharmaceutical Services, Inc, Ypsomed Holding AG.

  • Self-injection device market is growing with the highest CAGR.
  • Needle free injectors market segment is expected to dominate the North America self injection device market. However, wearable injectors market segment is expected to grow at the highest CAGR.
  • Novel drug delivery formulation is dominating the injectable drug delivery formulation market.

Inquiry Report @: databridgemarketresearch.com/inqui…g-delivery-market

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...